Farmasierra
Laura Lombao Marcos is a laboratory analyst at Farmasierra since October 2023, specializing in physical-chemical testing of pharmaceutical products to ensure quality control. Prior experience includes working as a Quality Control Laboratory Technician at Sika from March 2022 to October 2023, where Laura was responsible for sample collection and reception of raw materials and finished products. Additionally, Laura has held quality technician and administrative roles at Eurofins Megalab España S.A and various receptionist positions at CMS Albiñana & Suárez de Lezo, Asociación Española Contra el Cáncer, and Negocenter Business Center. Early experience includes laboratory technician duties at CSIC, focusing on theoretical model resolution and material analysis. Laura holds a degree in Chemistry from Universidad de Salamanca, obtained in 2020.
This person is not in any offices
Farmasierra
Grupo Farmasierra is a pharmaceutical group that specialises in research and development and the manufacture, distribution and commercialisation of medicinal products, food supplements and cosmetics. The Group consists of 205 employees distributed in its four business areas; it has a revenue of 40 million euros and is in full growth. It currently has offices in Spain (Madrid, Barcelona). The Group's activity ranges from the preliminary research needed to develop and optimise the production of a medicinal product, food supplements and cosmetics to the integral management of manufacturing its distribution and promotion. Grupo Farmasierra carries out contract manufacturing and technology development services at the international level for the entire European Union, and for over 20 additional countries. Moreover, it provides third parties with distribution services at the national level and commercialises its products in Spain and Portugal. The on-going incorporation of new knowledge is key to the consolidation of all its areas and its expansion over time. Therefore, Grupo Farmasierra attends major international forums on formulation and pharmaceutical innovation and is in contact with the main sources of specialised information, including several universities and research institutes.